Cite
Geographic Shifts in Antibacterial Drug Clinical Trial Enrollment: Implications for Generalizability.
MLA
Bart, Stephen M., et al. “Geographic Shifts in Antibacterial Drug Clinical Trial Enrollment: Implications for Generalizability.” Clinical Infectious Diseases, vol. 72, no. 8, Apr. 2021, pp. 1422–28. EBSCOhost, https://doi.org/10.1093/cid/ciaa246.
APA
Bart, S. M., Farley, J. J., Bala, S., Amini, T., & Cox, E. (2021). Geographic Shifts in Antibacterial Drug Clinical Trial Enrollment: Implications for Generalizability. Clinical Infectious Diseases, 72(8), 1422–1428. https://doi.org/10.1093/cid/ciaa246
Chicago
Bart, Stephen M, John J Farley, Shukal Bala, Thushi Amini, and Edward Cox. 2021. “Geographic Shifts in Antibacterial Drug Clinical Trial Enrollment: Implications for Generalizability.” Clinical Infectious Diseases 72 (8): 1422–28. doi:10.1093/cid/ciaa246.